FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chad Wiesenauer

Research Profile

Chemicals & Drugs

Disorders

Phenomena

Phosphorylation

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Jennifer Choi; Michele T Yip-Schneider; Faith Albertin; Chad A Wiesenauer; Yufang Wang; C Max Schmidt
The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
C Max Schmidt; Chad A Wiesenauer; James V Sitzmann
Long-term effects on diet after proctocolectomy for ulcerative colitis.
Patrick J Klein; C Max Schmidt; Chad A Wiesenauer; Jennifer N Choi; Earl A Gage; Michele T Yip-Schneider; Eric A Wiebke; Yufang Wang; Charles Omer; Judith Leopold
The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chad Wiesenauer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Jennifer Choi; Michele T Yip-Schneider; Faith Albertin; Chad A Wiesenauer; Yufang Wang; C Max Schmidt
The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
The Journal of surgical research 2008;150(2):219-26.
2008: C Max Schmidt; Chad A Wiesenauer; James V Sitzmann
Long-term effects on diet after proctocolectomy for ulcerative colitis.
American journal of surgery 2008;195(3):353-7; discussion 357.
2006: Patrick J Klein; C Max Schmidt; Chad A Wiesenauer; Jennifer N Choi; Earl A Gage; Michele T Yip-Schneider; Eric A Wiebke; Yufang Wang; Charles Omer; Judith Leopold
The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.
Neoplasia (New York, N.Y.) 2006;8(1):1-8.
2004: C Max Schmidt; Emilie S Powell; Constantin T Yiannoutsos; Thomas J Howard; Eric A Wiebke; Chad A Wiesenauer; Joel A Baumgardner; Oscar W Cummings; Lewis E Jacobson; Thomas A Broadie; David F Canal; Robert J Goulet; Eardie A Curie; Higinia R. Cardenes; John M Watkins; Patrick J Loehrer; Keith D Lillemoe; James A Madura
Pancreaticoduodenectomy: a 20-year experience in 516 patients.
Archives of surgery (Chicago, Ill. : 1960) 2004;139(7):718-25; discussion 725-7.
2004: Chad A Wiesenauer; Michele T Yip-Schneider; Yufang Wang; C Max Schmidt
Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
Journal of the American College of Surgeons 2004;198(3):410-21.
2003: C Max Schmidt; Yufang Wang; Chad A Wiesenauer
Novel combination of cyclooxygenase-2 and MEK inhibitors in human hepatocellular carcinoma provides a synergistic increase in apoptosis.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(8):1024-33.
2003: Chad A Wiesenauer; C Max Schmidt; Oscar W Cummings; Constantin T Yiannoutsos; Thomas J Howard; Eric A Wiebke; Robert J Goulet; Lee McHenry; Stuart Sherman; Glen A Lehman; Harvey Cramer; James A Madura
Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.
Archives of surgery (Chicago, Ill. : 1960) 2003;138(6):610-7; discussion 617-8.
2003: Michele T Yip-Schneider; Chad A Wiesenauer; C Max Schmidt
Inhibition of the phosphatidylinositol 3'-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(3):354-63.